Russell Investments Group, Ltd. - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 107 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$208,740
-23.4%
193,278
-8.5%
0.00%
-100.0%
Q2 2023$272,426
-2.5%
211,184
-0.2%
0.00%0.0%
Q1 2023$279,283
+19.6%
211,579
+35.9%
0.00%
Q4 2022$233,533
+33.4%
155,689
+4.2%
0.00%
Q3 2022$175,000
+1844.4%
149,465
+1605.2%
0.00%
Q2 2022$9,000
-96.7%
8,765
-90.4%
0.00%
Q1 2022$272,000
+29.5%
91,221
+14.6%
0.00%
Q4 2021$210,000
-31.1%
79,573
-5.8%
0.00%
-100.0%
Q3 2021$305,000
-16.4%
84,4490.0%0.00%0.0%
Q2 2021$365,000
-58.5%
84,449
-67.2%
0.00%
-50.0%
Q1 2021$879,000
-58.1%
257,502
-57.1%
0.00%
-50.0%
Q4 2020$2,100,000
-5.8%
599,946
-35.5%
0.00%
-20.0%
Q3 2020$2,229,000
+94.3%
930,548
+48.0%
0.01%
+66.7%
Q2 2020$1,147,000
+59.5%
628,550
+35.8%
0.00%
+50.0%
Q1 2020$719,000
+810.1%
462,762
+1137.3%
0.00%
Q4 2019$79,000
-58.0%
37,400
-62.7%
0.00%
Q3 2019$188,000
-47.6%
100,300
-27.2%
0.00%
-100.0%
Q2 2019$359,000
+348.8%
137,761
+345.8%
0.00%
Q1 2019$80,000
-82.6%
30,900
-83.8%
0.00%
-100.0%
Q4 2016$459,000190,7480.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,847,087$4,119,0003.26%
Sio Capital Management, LLC 1,333,696$2,974,0001.52%
Boxer Capital, LLC 700,000$1,561,0001.38%
Palo Alto Investors LP 5,386,534$12,012,0000.91%
ACUTA CAPITAL PARTNERS, LLC 747,748$1,667,0000.80%
SENZAR ASSET MANAGEMENT, LLC 1,443,003$3,217,897,0000.70%
Ghost Tree Capital, LLC 800,000$1,784,0000.52%
NEA Management Company, LLC 3,243,150$7,232,0000.38%
Rhenman & Partners Asset Management AB 850,000$1,896,0000.34%
Rock Springs Capital Management LP 1,750,000$3,903,0000.29%
View complete list of RIGEL PHARMACEUTICALS INC shareholders